Where It Comes From
Chloramben (3-amino-2,5-dichlorobenzoic acid), sold under the trade name Amiben, was developed by Amchem Products in the late 1950s and registered in 1960 as a selective pre-emergent herbicide for use in soybeans, peanuts, corn, and numerous other crops and gardens. [1] It works by inhibiting cell division in germinating weed seedlings, preventing root and shoot elongation before the weed emerges from the soil. As a substituted benzoic acid, it is water-soluble and moves readily through soil — a property that makes it both effective as a soil-applied herbicide and a potential groundwater contaminant in high-use areas. Following the standard carcinogenicity testing required under FIFRA reregistration, animal bioassays found evidence of increased liver tumor incidence in mice, leading to the EPA's Group C classification (possible human carcinogen) and later its listing as a probable carcinogen under older guidelines. [2] Chloramben was voluntarily canceled for many food uses in the United States in the 1990s–2000s as the registrant chose not to fund the complete data package required for reregistration under stricter modern FIFRA standards. It is currently registered for limited ornamental and non-food uses. [3]
How You Are Exposed
Agricultural workers who applied chloramben to soybeans and other crops were the primary occupationally exposed population during its period of peak use. Dermal exposure during mixing and loading was the dominant route. Dietary exposure from food residues was a secondary pathway for the general public. Groundwater contamination in high-use agricultural areas provided a drinking water exposure pathway. Current exposures are limited given the restricted registration.
Why It Matters
The liver tumor findings in rodent bioassays (the basis for the carcinogen classification) are consistent with chloramben's metabolism to reactive intermediates capable of hepatic DNA adduct formation. [2] Acute toxicity is relatively low — chloramben is only mildly toxic in standard acute toxicology studies. The environmental concern is groundwater contamination given its relatively high water solubility and soil mobility. Aquatic toxicity to plants (phytotoxicity) is significant.
Who Is at Risk
Former agricultural workers who applied chloramben through the 1970s–1990s, and current workers in the limited ornamental horticulture sector where it may still be registered, represent the at-risk population. People with private wells in historically treated soybean-growing regions may have historical groundwater exposures.
How to Lower Your Exposure
1. Check current registration status in your state — many food uses are canceled and the compound may not be legally applicable to crops. 2. Former applicators should inform their physicians of past occupational exposure for appropriate cancer surveillance. 3. Private well owners in former high-use soybean areas can test their wells for chloramben. 4. If applying to ornamental gardens, wear gloves and eye protection, observe re-entry intervals.
References
- [1][1] Weed Science Society of America. Herbicide Handbook, 9th ed.
- [2][2] US EPA (1988). Chloramben: Pesticide Tolerance. Cancer assessment and Risk-Benefit Summary.
- [3][3] EPA Pesticide Registration. Chloramben (PC Code 011401). https://www.epa.gov/pesticides
Recovery & Clinical Information
Body Half-Life
Chloramben is metabolized in the liver, with glucuronide and glycine conjugation as the primary pathways, and urinary excretion occurring within 24–48 hours. The compound does not significantly bioaccumulate. Its soil half-life is 2–4 weeks in most conditions.
Testing & Biomarkers
No routine clinical biomarker test for chloramben. Research methods use HPLC to measure chloramben and its conjugates in urine. Liver function tests (ALT, AST) are appropriate for evaluating significant exposures. For groundwater concern, water testing by a certified lab for benzoic acid herbicides.
Interventions
Remove from exposure source. Skin/eye contact: wash with soap and water or flush eyes. No specific antidote. For cancer surveillance in historically exposed workers: periodic liver function monitoring and imaging as recommended by an occupational physician.
Recovery Timeline
Chloramben clears from the body within 48 hours of last exposure. Liver function abnormalities, if present, normalize over weeks. Cancer risk from past cumulative exposure remains but does not increase after ending exposure.
Recovery References
- [1]EPA Reregistration Eligibility Decision: Chloramben.
- [2]WSSA Herbicide Handbook, 9th ed. Chloramben, pp. 52–54.